doi:10.1111/j.1742-7843.2011.00841.x
Lymphatic targeting may be achieved via the delivery of macromolecular therapeutics (for example, proteins and peptides), small-molecule therapeutics in association with macromolecular carriers (for example, nanoparticles, polymers, liposomes and dendrimers) or small-molecule therapeutics that associate, in situ , with endogenous macromolecular constructs (for example, lipoproteins and proteins) or cells that are transported from interstitial tissues via lymphatic rather than blood capillaries
To see if a specific medication or ingredient is prohibited, please visit GlobalDRO.com
A three-dimensional arrayed microfluidic blood-brain barrier model with integrated electrical sensor array
With regular use, this Glutathione Facial Deep Cleanser helps maintain hydration, improve skin clarity, and promote a healthy-looking glow